Saturday 17 October 2026
Export SIGA’s income statement to Excel — free account
Siga Technologies Inc.
SIGA Healthcare Drug Manufacturers Specialty & Generic
Siga Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $94.6 million, down 31.8% from fiscal 2024. In the quarter to June 2026, revenue fell 49.5%, EPS fell 66.0% and free cash flow fell 76.0%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
3.17
0.02
−0.63%
Follow SIGA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
1 | 1 | 6 | 2 | 8 | 6 | 7 | 7 | 5 | 5 |
P/E ratio |
0.00 | 0.00 | 1.50 | 0.00 | 10.10 | 8.07 | 15.12 | 6.10 | 7.33 | 18.28 |
Altman Z-Score |
(4.22) | (4.80) | 11.73 | 2.06 | 20.13 | 11.06 | 14.79 | 6.46 | 11.40 | 14.28 |
P/S ratio |
11.18 | 30.86 | 1.32 | 14.45 | 4.61 | 4.24 | 4.63 | 2.97 | 3.09 | 4.62 |
Altman Z″-Score (non-manufacturers) |
(9.59) | (12.32) | 14.49 | 1.84 | 14.35 | 11.98 | 13.11 | 10.07 | 15.08 | 16.02 |
P/FCF ratio |
0.00 | 0.00 | 9.19 | 0.00 | 8.06 | 49.50 | 12.34 | 4.38 | 8.79 | 10.14 |
P/Operating CF |
(6.47) | (46.43) | (175.82) | (27.10) | 12.54 | 35.18 | (63.25) | 5.26 | 7.60 | (25.92) |
Beneish M-Score |
(3.04) | (3.48) | 38.80 | 27.61 | (0.28) | 18.96 | (2.82) | (3.36) | (2.12) | (4.02) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 36 |
P/B ratio |
0.00 | 0.00 | 6.14 | 3.95 | 4.44 | 3.25 | 3.01 | 2.11 | 1.98 | 2.20 |
Price to Tangible BV |
0.00 | 0.00 | 6.19 | 3.99 | 4.47 | 3.27 | 3.03 | 2.12 | 1.99 | 2.21 |
EV/Sales |
13.16 | 34.32 | 1.25 | 14.38 | 4.94 | 4.66 | 5.17 | 3.03 | 3.11 | 4.66 |
EV/EBITDA |
0.00 | 0.00 | 1.68 | 0.00 | 7.26 | 6.94 | 13.26 | 5.04 | 6.12 | 18.18 |
EV/Operating CF |
(1.69) | (22.90) | 8.67 | (21.12) | 8.63 | 54.13 | 13.77 | 4.47 | 8.86 | 10.15 |
EV/FCF |
(1.69) | (22.76) | 8.68 | (21.09) | 8.63 | 54.37 | 13.78 | 4.48 | 8.86 | 10.23 |
Quick Ratio |
5.91 | 4.75 | 10.06 | 1.80 | 11.56 | 6.13 | 6.70 | 3.16 | 6.97 | 8.79 |
Current Ratio |
9.74 | 5.49 | 10.70 | 1.96 | 13.70 | 6.85 | 8.63 | 4.42 | 9.12 | 11.83 |
Net Debt/EBITDA |
(0.90) | (2.16) | (0.10) | 45.09 | (1.39) | (1.15) | (2.29) | (1.78) | (2.20) | (6.39) |
Debt/Assets |
41.34% | 49.11% | 37.13% | 40.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.23) | (0.22) | 0.73 | 0.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.09 | 0.08 | 2.74 | 0.13 | 0.72 | 0.73 | 0.54 | 0.62 | 0.56 | 0.41 |
Operating CF/Net income |
2.94 | 0.51 | 0.16 | 2.51 | 1.27 | 0.17 | 1.23 | 1.39 | 0.82 | 1.87 |
Capex/Depreciation |
(0.14) | (0.76) | (1.47) | (0.06) | (0.03) | (0.10) | 0.00 | (0.04) | (0.08) | (0.63) |
Interest Coverage |
(12.95) | (1.28) | 22.94 | (0.15) | 28.01 | 880.36 | 41.38 | — | — | — |
| 13.88% | 11.87% | (383.07%) | (7.22%) | 49.51% | 45.68% | 19.68% | 37.09% | 28.70% | 11.23% | |
| (22.90%) | (23.71%) | 242.34% | (3.60%) | 32.34% | 38.10% | 16.55% | 30.29% | 23.75% | 10.04% | |
ROIC |
0.00% | 0.00% | 334.46% | (8.62%) | 443.69% | 78.23% | 37.39% | 111.88% | 72.41% | 33.78% |
Return on Tangible Assets |
(63.66%) | (118.06%) | 383.03% | (7.96%) | 41.66% | 38.45% | 20.41% | 36.56% | 28.60% | 11.88% |
Average Days of Receivables |
76.82 | 53.61 | 1.50 | 56.89 | 9.76 | 228.42 | 149.61 | 55.12 | 55.69 | 12.60 |
Research and Development Expense of Revenue |
131.51% | 135.95% | 2.73% | 49.75% | 8.75% | 7.44% | 20.33% | 11.74% | 8.87% | 21.10% |
Selling, General and Administrative Expense of Revenue |
91.50% | 100.28% | 2.70% | 49.56% | 11.78% | 13.49% | 31.70% | 15.75% | 18.12% | 22.43% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
5.17% | 8.97% | 0.48% | 7.91% | 1.08% | 0.95% | 1.61% | 1.47% | 2.62% | 3.89% |
Graham Net Nets |
(2.26) | (1.14) | 0.03 | 0.21 | 0.21 | 0.30 | 0.31 | 0.44 | 0.47 | 0.44 |
Graham Number |
8.83 | 6.55 | 12.33 | 0.00 | 5.15 | 6.97 | 4.94 | 7.70 | 7.48 | 4.57 |
Earnings Yield |
(23.55%) | (9.69%) | 66.46% | (1.99%) | 9.90% | 12.40% | 6.62% | 16.40% | 13.64% | 5.47% |
Free Cash Flow Yield |
(69.73%) | (4.89%) | 10.88% | (4.72%) | 12.41% | 2.02% | 8.11% | 22.81% | 11.38% | 9.87% |
Revenue per Share |
0.26 | 0.16 | 5.97 | 0.33 | 1.58 | 1.77 | 1.52 | 1.96 | 1.95 | 1.32 |
Operating CF per Share |
(2.04) | (0.23) | 0.86 | (0.22) | 0.90 | 0.15 | 0.57 | 1.33 | 0.68 | 0.61 |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(2.04) | (0.23) | 0.86 | (0.22) | 0.90 | 0.15 | 0.57 | 1.33 | 0.68 | 0.60 |
Cash per Share |
0.68 | 0.39 | 1.40 | 1.99 | 1.49 | 1.37 | 1.35 | 2.10 | 2.18 | 2.17 |
Shareholders Equity per Share |
(5.03) | (4.10) | 1.29 | 1.21 | 1.64 | 2.31 | 2.33 | 2.76 | 3.03 | 2.78 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(5.03) | (4.10) | 1.29 | 1.21 | 1.64 | 2.31 | 2.33 | 2.76 | 3.03 | 2.78 |
Free Cash Flow |
(116.84) | (18.49) | 68.77 | (18.23) | 71.50 | 11.44 | 41.61 | 94.78 | 48.72 | 43.12 |
Working Capital |
62.06 | 30.55 | 109.95 | 88.31 | 133.12 | 178.27 | 164.27 | 184.87 | 205.71 | 194.86 |
Capital Expenditures |
(0.02) | (0.10) | (0.10) | (0.03) | (0.02) | (0.05) | — | (0.02) | (0.04) | (0.35) |
Net Current Asset Value |
(379.24) | (430.44) | 20.76 | 79.26 | 123.57 | 168.34 | 160.91 | 181.50 | 202.51 | 192.21 |
EV/EBIT |
0.00 | 0.00 | 1.68 | 0.00 | 7.31 | 6.98 | 13.42 | 5.07 | 6.17 | 18.61 |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 1.78 | 0.00 | 6.82 | 6.36 | 12.01 | 4.97 | 6.12 | 18.44 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.58 | 0.95 | 0.41 | 0.20 | 0.25 | 0.22 | 0.28 | 0.40 | 0.41 | 0.52 |
Cash ROIC |
64.19% | 8.35% | 23.67% | (5.38%) | 28.87% | 4.12% | 15.47% | 27.31% | 13.12% | 12.19% |
Accounts Receivable Turnover |
4.39 | 4.95 | 253.67 | 8.73 | 33.29 | 3.07 | 1.72 | 4.21 | 6.56 | 7.74 |
Accounts Payable Turnover |
0.00 | 0.00 | 63.15 | 0.75 | 6.83 | 10.04 | 3.88 | 7.41 | 22.38 | 27.44 |
Inventory Turnover |
0.00 | 0.00 | 32.34 | 0.28 | 0.99 | 0.83 | 0.35 | 0.34 | 0.55 | 0.60 |
Average Days of Payables |
0.00 | 0.00 | 6.47 | 625.26 | 31.53 | 44.59 | 117.39 | 29.82 | 15.64 | 10.13 |
Days of Inventory on Hand |
0.00 | 0.00 | 11.14 | 1,976.28 | 499.88 | 428.94 | 1,374.03 | 1,314.98 | 578.18 | 602.78 |
Average Receivables |
3.42 | 2.48 | 1.88 | 3.06 | 3.75 | 43.50 | 64.53 | 33.27 | 21.15 | 12.21 |
Average Payables |
3.23 | 1.92 | 1.51 | 2.37 | 2.17 | 1.65 | 2.69 | 2.41 | 1.40 | 1.08 |
Average Inventory |
19.33 | 14.60 | 2.95 | 6.28 | 14.96 | 19.89 | 29.39 | 51.75 | 56.89 | 49.31 |
Average Assets |
173.36 | 152.83 | 174.06 | 201.00 | 174.20 | 182.28 | 204.88 | 224.69 | 249.34 | 231.90 |
Average Common Equity |
(285.92) | (305.28) | (110.11) | 100.35 | 113.79 | 152.05 | 172.24 | 183.51 | 206.33 | 207.31 |
Columns are period end dates